besylate

besylate

 [bes´ĭ-lāt]
USAN contraction for benzenesulfonate.

be·syl·ate

(bes'il-āt),
USAN-approved contraction for benzenesulfonate.

besylate

/bes·y·late/ (bes´ĭ-lāt) USAN contraction for benzenesulfonate.

besylate

a contraction for benzenesulfonate.

besylate

USAN contraction for benzenesulfonate.
References in periodicals archive ?
Nebraska is currently planning to execute inmates with a never-before-tried mix of four drugs: diazepam (more commonly known as Valium), potassium chloride, cisatracurium besylate (a paralytic), and fentanyl citrate.
The company added that Consensi is comprised of two FDA approved drugs, celecoxib (Celebrex), a COX-2 inhibitor, for the treatment of pain caused by osteoarthritis, and amlodipine besylate (Norvasc), a calcium channel blocker for lowering blood pressure.
Amlodipine besylate (AMLO) is a long-acting dihydropyridine calcium antagonist whereas losartan potassium (LST) is an angiotensin II type 1 receptor antagonist; both these agents are currently being used in hypertension.
Aliskiren, amlodipine besylate, and hydrochlorothiazide (Amturnide).
The company's key APIs are sildenafil citrate, amlodipine besylate, cinnarizine, omeprazole powder, triclabendazole, and others.
Court of Appeals for the Federal Circuit in March invalidated the patent on Norvasc's key ingredient, amlodipine besylate.
Zydus Healthcare (SA) has launched Amlodac, the first generic amlodipine with the original besylate salt.
Food and Drug Administration (FDA) for a fixed dose combination of two antihypertensives, the calcium channel blocker (CCB) amlodipine besylate (currently marketed by Pfizer as Norvasc) and the angiotensin receptor blocker (ARB) olmesartan medoxomil, or Benicar.
Eventually it was presented as a besylate salt and produced for clinical testing as atracurium besylate, an aqueous solution of 10 mg/ml.
market with safe, effective and affordable products, including our recent launches of Atorvastatin (*brand Lipitor[R]) and Atorvastatin-Amlodipine besylate (** brand Caduet[R]).
Data from the trial further revealed that the product was more efficacious at decreasing hypertension than the widely used hypertension drug, amlodipine besylate.
Court of Appeals for the Federal Circuit in Washington held invalid the patent on the drug's key ingredient, amlodipine besylate, overturning a January 2006 ruling by District Judge James M.